https://www.miragenews.com/anticancer-drugs-may-boost-immunotherapy-success-1375173/
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a
anticancer drugsmayboostimmunotherapysuccess
https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.661464/full
Purpose: It is well known that anticancer drugs used for treating breast cancer can cause cardiac toxicity, less is known about vascular toxicity. The aim of...
arterial stiffnessanticancer drugsfrontierseffectsused
https://www.sciencedaily.com/releases/2013/04/130403071435.htm
Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy...
resistant canceranticancer drugscisplatincellssensitive